BWM
BIIB icon

Bernard Wealth Management’s Biogen BIIB Stock Holding History

Bernard Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38K Hold
11
– – ﹤0.01% 272
2026
Q1 		$2.02K Hold
11
– – ﹤0.01% 291
2025
Q4 		$1.94K Hold
11
– – ﹤0.01% 286
2025
Q3 		$1.54K Hold
11
– – ﹤0.01% 280
2025
Q2 		$1.38K Hold
11
– – ﹤0.01% 274
2025
Q1 		$1.51K Hold
11
– – ﹤0.01% 325
2024
Q4 		$1.68K Buy
+11
New +$1.85K ﹤0.01% 272

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bernard Wealth Management's BIIB Position: Q2 2026 in Review

Bernard Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 11 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Bernard Wealth Management first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Bernard Wealth Management held 11 shares of Biogen worth $2.38K as of Q2 2026.
  • Bernard Wealth Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Bernard Wealth Management's portfolio in Q2 2026, its #272 holding.
  • Bernard Wealth Management first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Bernard Wealth Management's 13F filing for Q2 2026, filed 21 Aug 2026.